Sartorius Stedim Biotech: Statement on Share Capital

Sartorius Stedim Biotech SA published a statement regarding its share capital structure as of April 30, 2026. The company, based in Aubagne, France, announced that it holds 97,330,405 shares. The total number of theoretical voting rights, including treasury shares, amounts to 164,770,639. The net voting rights, however, total 164,718,031.

This statement was made in accordance with Article L 233-8-II of the French Commercial Code and Article 223-6 of the AMF General Regulation. The press release was issued by EQS Group, emphasizing the need for listed companies to regularly provide this information to the public to ensure full transparency towards investors.